查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966243

2026-2034年全球人乳寡糖（HMO）市場規模、佔有率、趨勢和成長分析報告

Global Human Milk Oligosaccharides (HMO) Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 143 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計人乳低聚醣 (HMO) 市場將從 2025 年的 4.1349 億美元成長到 2034 年的 27.2748 億美元，2026 年至 2034 年的複合年成長率為 23.32%。

由於對先進嬰幼兒營養解決方案的需求不斷成長，全球母乳寡糖 (HMO) 市場正快速成長。 HMO 是一種生物活性碳水化合物，能夠支持嬰幼兒的免疫系統發育和腸道健康。意識提升，是推動市場成長的主要因素。

關鍵成長要素包括嬰兒奶粉產量增加、基於生物技術的HMO合成技術步驟以及腸道菌叢健康研究的進展。製造商正將HMO添加到高階嬰兒營養產品中，以模擬母乳的益處。各地監管部門的核准也推動了其商業化進程。

展望未來，隨著新型HMO研究的深入以及其在眾多健康領域的應用拓展，市場預計將持續擴張。在新興市場，由於出生率和可支配收入的增加，預計市場需求將強勁成長。大規模生產技術的創新將提升產品的價格競爭力。隨著嬰幼兒營養標準的不斷完善，HMO市場可望維持持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球人乳低聚醣（HMO）市場：按類型分類

  • 市場分析、洞察與預測
  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

第5章：全球人乳寡糖（HMO）市場：依應用領域分類

  • 市場分析、洞察與預測
  • 嬰兒奶粉
  • 功能性食品和飲料
  • 食品補充劑
  • 其他用途
  • 其他

第6章：全球人乳寡糖（HMO）市場：依濃度分類

  • 市場分析、洞察與預測
  • 中性的
  • 酸性

第7章 全球人乳寡糖（HMO）市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • DSM
    • BASF SE
    • CHR Hansen Holding A/S
    • DuPont
    • NestlAfA（C）
    • Biosynth Carbosynth
    • Inbiose NV
    • Gnubiotics Sciences SA
    • Abbott Laboratories
    • Royal Friesland Campina NV
    • Elicityl SA
    • Dextra Laboratories
簡介目錄
Product Code: VMR11210620

The Human Milk Oligosaccharides (HMO) Market size is expected to reach USD 2727.48 Million in 2034 from USD 413.49 Million (2025) growing at a CAGR of 23.32% during 2026-2034.

The Global Human Milk Oligosaccharides (HMO) Market has grown rapidly due to increasing demand for advanced infant nutrition solutions. HMOs are bioactive carbohydrates that support immune development and gut health in infants. Rising awareness among parents about scientifically formulated infant products has significantly driven market growth.

Key growth drivers include expanding infant formula production, technological advancements in biotechnology-based HMO synthesis, and growing research on gut microbiome health. Manufacturers are incorporating HMOs into premium infant nutrition products to replicate the benefits of human breast milk. Regulatory approvals in various regions further support commercialization.

Looking ahead, the market is expected to expand with continued research into additional HMO types and broader health applications. Emerging markets are anticipated to generate strong demand due to rising birth rates and disposable incomes. Innovation in large-scale production technologies will enhance affordability. As infant nutrition standards evolve, the HMO market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • 2' FL
  • 3' FL
  • 3' SL
  • 6' SL

By Application

  • Infant Formula
  • Functional Food & Beverages
  • Food Supplements
  • Other Applications
  • Other

By Concentration

  • Neutral
  • Acidic

COMPANIES PROFILED

  • DSM, BASF SE, CHR Hansen Holding AS, DuPont, Nestl, Biosynth Carbosynth, Inbiose NV, Gnubiotics Sciences SA, Abbott Laboratories, Royal Friesland Campina NV, Elicityl SA, Dextra Laboratories

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY TYPE 2022-2034 (USD MN and Kilo Tons)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. 2' FL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 4.3. 3' FL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 4.4. 3' SL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 4.5. 6' SL Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 5. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY APPLICATION 2022-2034 (USD MN and Kilo Tons)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Infant Formula Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 5.3. Functional Food & Beverages Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 5.4. Food Supplements Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 5.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 5.6. Other Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 6. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY CONCENTRATION 2022-2034 (USD MN and Kilo Tons)

  • 6.1. Market Analysis, Insights and Forecast Concentration
  • 6.2. Neutral Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)
  • 6.3. Acidic Estimates and Forecasts By Regions 2022-2034 (USD MN and Kilo Tons)

Chapter 7. GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET: BY REGION 2022-2034(USD MN and Kilo Tons)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
    • 7.2.1 By Type
    • 7.2.2 By Application
    • 7.2.3 By Concentration
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
    • 7.3.1 By Type
    • 7.3.2 By Application
    • 7.3.3 By Concentration
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
    • 7.4.1 By Type
    • 7.4.2 By Application
    • 7.4.3 By Concentration
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
    • 7.5.1 By Type
    • 7.5.2 By Application
    • 7.5.3 By Concentration
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Kilo Tons)
    • 7.6.1 By Type
    • 7.6.2 By Application
    • 7.6.3 By Concentration
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 DSM
    • 9.2.2 BASF SE
    • 9.2.3 CHR Hansen Holding A/S
    • 9.2.4 DuPont
    • 9.2.5 NestlAfA(C)
    • 9.2.6 Biosynth Carbosynth
    • 9.2.7 Inbiose N.V
    • 9.2.8 Gnubiotics Sciences S.A
    • 9.2.9 Abbott Laboratories
    • 9.2.10 Royal Friesland Campina N.V
    • 9.2.11 Elicityl S.A
    • 9.2.12 Dextra Laboratories